GMT EIGHT - Announcement

CONGYU INTE AGR(00875) plans to issue 75.8514 million shares, raising approximately 418 million Hong Kong dollars net.

CONGYU INTE AGR(00875) announced that on February 21, 2025, the company plans to issue a total of 75.8514 million subscription shares to subscribers, equivalent to 16.67% of the total number of shares issued after the completion of the recent enlargement. The subscription price is HK$0.560 per share. The total amount of funds raised from the issuance of subscription shares will be HK$42.4768 million. The net amount of funds raised from the subscription will be approximately HK$41.8 million. The company plans to use HK$25 million of the net funds for the group's procurement activities; HK$14 million to repay other loans and accounts payable; and HK$2.8 million for the group's general operating funds.

21/02/2025

TRADEGO (08017) spent 592,600 Hong Kong dollars to repurchase 1.76 million shares on February 21st.

TRADGO (08017) announced on February 21, 2025, to repurchase 1.76 million shares at a cost of HKD 592,600.

21/02/2025

TRENDZON HLDG(01865): Zhao Jianhong appointed as Executive Director

TRENDZON HLDG (01865) announced that as of February 21, 2025, Mr. Dong Changzhou has been appointed as a non-executive director. Ms. Zhao Jianhong has been appointed as an executive director.

21/02/2025

TRENDZON HLDG (01865) intends to change its name to "Pengao Holdings Group Limited"

TRENDZON HLDG (01865) announced that the board of directors recommends changing the company's English name from "Trendzon Holdings Group Limited" to "Pengo Holdings Group Limited", and changing its dual Chinese and foreign names from "TRENDZON HLDG Group Limited" to "Pengo Holdings Group Limited".

21/02/2025

QINGDAO PORT (06198) plans to adjust the original restructuring plan to only acquire 100% equity of the oil company and 50% equity of Rizhao Shihua.

QINGDAO PORT (06198) announced that, due to the bankruptcy of some important customers of the target companies in the original restructuring plan, such as Joint Pipeline and Gangyuan Pipeline, not progressing as expected, and in order to protect the interests of the company and small and medium shareholders, the company has decided to withdraw the original restructuring plan application from the Shanghai Stock Exchange. The company plans to adjust the original restructuring plan to no longer acquire 53.88% equity of Joint Pipeline and 51.00% equity of Gangyuan Pipeline, while retaining the acquisition of 100% equity of an oil company and 50.00% equity of Rizhao Sihuahua in cash. This adjustment constitutes a significant revision under Rules 14.36 and 14A.35 of the Hong Kong Listing Rules. The company has signed termination agreements with Rizhao Port Co., Ltd. Group and Yantai Port Group on the original restructuring plan on February 21, 2025, with no breach of contract by the company or related parties. On February 21, 2025, the Shanghai Stock Exchange decided to terminate the review of the company's original restructuring plan. Due to the adjustment of the original restructuring plan, the company entered into an asset purchase agreement with Rizhao Port Co., Ltd. Group on February 21, 2025. Under this agreement, the company conditionally agreed to purchase the target assets in cash, namely 100% equity of the oil company, and 50.00% equity of Rizhao Sihuahua, for a total consideration of RMB 4.62865 billion. The oil company is a wholly-owned subsidiary of Rizhao Port Co., Ltd. Group, mainly engaged in liquid bulk cargo port handling, tank storage, and other businesses. As of the date of this announcement, the actual controller of the oil company is the Shandong Provincial State-owned Assets Supervision and Administration Commission. Rizhao Sihuahua is a joint venture of Rizhao Port Co., Ltd. Group and Trade and Development Group, mainly engaged in liquid bulk cargo port handling business. As of the date of this announcement, Rizhao Sihuahua is 50% owned by Rizhao Port Co., Ltd. Group and Trade and Development Group, with the actual controllers being the Shandong Provincial State-owned Assets Supervision and Administration Commission and the State-owned Assets Supervision and Administration Commission of the State Council respectively. The announcement stated that this transaction is an important measure for Shandong Port Group to address competition issues in the industry, injecting quality liquid bulk cargo terminal assets of Rizhao Port Co., Ltd. Group into the company. It is beneficial to harness synergies in relevant businesses, optimize the allocation of port resources in Shandong Province, improve the comprehensive utilization of port resources, avoid resource waste, reduce industry competition, and protect the interests of the company and shareholders.

21/02/2025

WORLD SUPER (08612): Luo Jianhui has been appointed as an independent non-executive director.

WORLD SUPER (08612) announced that Luo Jianhui has been appointed as an independent non-executive director, chairman of the board audit committee, member of the board nomination committee, and member of the board remuneration committee, all appointments will take effect from February 21, 2025.

21/02/2025

CARDIOFLOW-B (02160): ANCHORMAN left atrial appendage occluder system and its guiding system have obtained CE marking approval.

CARDIOFLOW-B(02160) announces that the AnchorMan Left Atrial Appendage Closure System and its guiding system have obtained the CE mark (indicating certification that products sold within the European Economic Area meet health, safety, and environmental standards). The AnchorMan Left Atrial Appendage Closure System and AnchorMan Left Atrial Guiding System are products independently developed by the company's subsidiary, Shanghai Zuoxin Medical Technology Co., Ltd. (Shanghai Zuoxin). The AnchorMan Left Atrial Appendage Closure System is expected to be used for percutaneous closure of the left atrial appendage to prevent left atrial thromboembolism. The AnchorMan Left Atrial Guiding System is compatible with the AnchorMan Left Atrial Appendage Closure System and provides access to the femoral vein and interatrial septum. Both systems have been approved by the China National Medical Products Administration. The AnchorMan Left Atrial Appendage Closure System is currently the only approved semi-closed left atrial appendage closure device in China. Furthermore, obtaining the CE mark approval for the AnchorMan Left Atrial Appendage Closure System and AnchorMan Left Atrial Guiding System signifies that their innovative R&D design and excellent clinical performance have reached international standards. This provides a prerequisite for entering the European structural heart disease market and offers strong support for expanding into more international markets. It is a crucial milestone in the company's development and globalization strategy, with the potential to broaden revenue sources, enhance global competitiveness, and bring more opportunities on the international stage, benefiting more patients with structural heart disease.

21/02/2025

REF HOLDINGS(01631) issues profit warning, expecting a decrease of no less than 50% in shareholders' net profit for the fiscal year 2024.

REF Holdings (01631) announced that it expects the company's attributable profit for the year ending December 31, 2024 to decrease by no less than 50%, compared to approximately HK$11.7 million in the same period last year. The expected decrease in profit is mainly due to a decline in revenue; an increase in share-based payment expenses recognized under applicable accounting standards as a result of issuing company share options to certain eligible participants during the year; and an increase in credit loss provisions for expected trade receivables.

21/02/2025

NEW WORLD DEV (00017) expects the mid-term core operating profit to be between HK$4.35 billion and HK$4.55 billion.

On February 21st, NEW WORLD DEV (00017) issued a performance forecast, estimating that the core operating profit for the mid-term of the 2025 fiscal year may be between 4.35 billion and 4.55 billion Hong Kong dollars, excluding non-recurring gains and losses. Compared to the first half of the 2024 fiscal year, NEW WORLD DEV's profit was affected by other non-recurring factors such as impairment provisions, reduction in fixed-rate bond redemption gains, and disappearance of one-off gains. Industry insiders pointed out that with weakened market expectations, Hong Kong developers need to make impairment provisions for investments and property development, which is a risk management tool in accounting standards and reflects the prudence principle of real estate enterprises. Recognizing asset impairments does not necessarily mean significant changes in the company's production and operations or direct impact. On the same day, five units were sold in a single day at the Royal Palace project in North Point, Hong Kong, generating nearly 63 million Hong Kong dollars in cash. The project has recorded a total of 238 transactions this week, with an overall clearance rate of 93%, recording a total of 261 transactions and cashing out nearly 3 billion Hong Kong dollars, with an average price per square foot of approximately 22,500 Hong Kong dollars.

21/02/2025

Goldstream Invest (01328): Redwood subscribes for 780,000 shares of Marketingforce.

GOLDSTREAM INV(01328) announces that on February 21, 2025, its wholly-owned subsidiary Redwood has agreed to subscribe for 780,000 shares of MARKETINGFORCE at a total price of approximately HK$46.8 million (excluding transaction costs) through a placement agent, equivalent to HK$60.00 per share of MARKETINGFORCE. The subscription is expected to be completed by February 28, 2025, or earlier.

21/02/2025

Contact: contact@gmteight.com